论文部分内容阅读
目的:探讨沐舒坦雾化吸入联合咳喘贴治疗小儿喘息性支气管炎的疗效。方法:选取480例小儿喘息性支气管炎患者,按随机分配原则分为观察组和对照组,每组各240例。对照组予以沐舒坦治疗,观察组在对照组治疗的基础上加用咳喘贴。用药2周后,评价两组患者治疗效果。结果:观察组的总有效率为93.75%,对照组的总有效率为81.25%,观察组的疗效优于对照组,差异有统计学意义(P<0.01)。观察组的咳嗽消失时间、气喘消失时间、哮鸣音消失时间和湿啰音消失时间明显短于对照组,差异有统计学意义(P<0.01)。结论:沐舒坦雾化吸入联合咳喘贴治疗小儿喘息性支气管炎疗效显著,安全有效,具有临床推广价值。
Objective: To investigate the efficacy of mucosolvan inhalation and cough paste in the treatment of asthmatic bronchitis in children. Methods: A total of 480 pediatric asthmatic bronchitis patients were randomly divided into observation group and control group, with 240 cases in each group. The control group was treated with mucosolvan, and the observation group was given Kechuan paste on the basis of the control group. After 2 weeks of treatment, the treatment effect was evaluated in both groups. Results: The total effective rate was 93.75% in the observation group and 81.25% in the control group. The curative effect of the observation group was better than that of the control group (P <0.01). The observation group cough disappear time, asthma disappear time, wheeze disappearance time and wet rales disappear time was significantly shorter than the control group, the difference was statistically significant (P <0.01). Conclusion: Mucosolvan inhalation combined cough paste treatment of children with asthmatic bronchitis significant effect, safe and effective, with clinical value.